CrossRef The progress of molecules and strategies for the treatment of HBV infection Youlu Pan, Heye Xia, Yanwen He, Shenxin Zeng, Zhengrong Shen, Wenhai Huang Frontiers in Cellular and Infection Microbiology .2023;[Epub] CrossRef Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapy Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen, James Fung Expert Review of Gastroenterology & Hepatology .2023
Read How To Check if a Medicine or Supplement Has Aspirin, Other NSAIDs, Vitamin E, or Fish Oil
Frequently asked questions Can I use regular sterile water instead of bacteriostatic water
Factors Indicating Need for Dose Escalation Increase doses when minimal subjective improvements after 3-4 weeks at current dose, IGF-1 levels show minimal or no meaningful increase from baseline after an adequate trial period (e.g., 812 weeks), good tolerance without significant side effects suggesting room for higher dosing, and treatment goals require more aggressive approach than current dose provides
C., Emerson, A
